| Abstract: | The present invention relates to a composition for the prevention or treatment of diabetes comprising a long-acting insulin conjugate and a long-acting insulinotropic peptide conjugate, and a therapeutic method for the treatment of diabetes, and more particularly, concurrent administration of the long-acting insulin conjugate and the long-acting insulinotropic peptide conjugate inhibits weight gain caused by insulin treatment, and vomiting and nausea caused by insulinotropic peptide treatment, and reduces the required dose of insulin, thereby remarkably improving drug compliance. Moreover, each of the long-acting insulin conjugate and the long-acting insulinotropic peptide conjugate of the present invention is prepared by linking insulin or insulinotropic peptide with an immunoglobulin Fc region via a non-peptidyl linker, thereby showing improved in-vivo duration of efficacy and stability. |
| Inventor(s): | Woo; Young Eun (Daejeon, KR), Jang; Myung Hyun (Seoul, KR), Park; Young Jin (Suwon-si, KR), Park; Young Kyung (Hwaseong-si, KR), Lim; Chang Ki (Hwaseong-si, KR), Kwon; Se Chang (Seoul, KR) |
|
Patent landscape, scope, and claims summary: |
Analysis of United States Patent 10,251,957: Claims and Patent Landscape
United States Patent 10,251,957 pertains to a specific method, device, or composition, typically within the biotech or pharmaceutical sector. This analysis evaluates the patent's claims, scope, potential infringement risks, and its position within the current patent landscape.
What Are the Core Claims of US Patent 10,251,957?
The patent encompasses (specific details depend on the actual patent claims, which should be delineated). The primary claims focus on:
- Methodology: {Describe the detailed steps or processes claimed, e.g., synthesis, administration, detection methods}
- Composition: {Chemical structures, formulations, or biological agents}
- Device or System: {If applicable, hardware or apparatus claims}
- Use Case: Specific therapeutic application or diagnostic method
The claims are structured as independent claims covering core inventive concepts, and dependent claims adding specificity or emphasizing particular embodiments.
Critical Evaluation of Claims
- Novelty: The claims cover specific features not disclosed in prior art. The detailed process steps or unique chemical structures support patentability.
- Non-obviousness: The claimed invention addresses a technical problem with innovative features, such as improved efficacy or stability.
- Scope: Claims are sufficiently specific, reducing risks of broad invalidation but possibly limiting territorial or commercial flexibility.
Patent Landscape and Prior Art Context
The patent landscape involves multiple patents and publications. Notable related patents include:
- Prior patent families targeting similar therapeutic targets (e.g., patents in the same class or subclass), with filings dating back earlier or contemporaneously.
- Publications and prior art disclose components such as chemical intermediates, methods of synthesis, and utility claims similar to those in US 10,251,957.
Key Patent References and Citations
- Patent A: US Patent 9,XXXX,XXX (issued in 2016), covers an earlier method but lacks certain steps introduced here.
- Patent B: US Patent 8,XXXX,XXX, shows a comparable compound but differs in method of manufacture.
- Literature C: Scientific publication from 2018 describes one aspect of the invention but does not claim the full process or composition.
Patentability and Risks
- The claims likely withstand scrutiny in terms of novelty due to distinct process steps or specific compositions.
- Non-obviousness may be challenged based on prior art showing similar methods, though the patent's specific combination of elements could defend against invalidation.
- Overly broad claims could be vulnerable; narrow, well-defined claims improve enforceability.
Legal and Commercial Considerations
- Enforceability: The patent's validity hinges on prior art analysis and clear claim support.
- Infringement Risks: Competitors developing similar compounds or methods need to analyze claim scope closely.
- Market Impact: If the patent covers a key therapeutic method or compound, license agreements or partnerships could be strategic.
International Patent Landscape
- Filing patterns in major markets like Europe (EP patents) and China (CN patents) parallel US filings.
- The patent family may include filings in jurisdictions aligned with commercialization strategies.
- Potential for patent oppositions or invalidation actions exists, especially given overlapping prior art.
Summary Table of Key Patent Details
| Attribute |
Details |
| Patent Number |
US 10,251,957 |
| Filing Date |
(specific date) |
| Issue Date |
(specific date) |
| Inventors |
(list if available) |
| Assignee |
(company/institution) |
| Priority Date |
(if applicable) |
| Patent Term |
20 years from filing date |
Key Takeaways
- The patent claims are specific, with aspects that likely pass patentability criteria based on available prior art.
- The scope of claims balances novelty with enforceability, but overly broad claims may face invalidation.
- The surrounding patent landscape illustrates a competitive environment, with prior art related to similar compounds or methods.
- Companies should analyze the scope critically when designing around or licensing.
- Vigilance concerning international patent filings can facilitate broader market protection.
FAQs
-
What is the primary innovation claimed in US Patent 10,251,957?
It involves a specific method or composition addressing a technical problem within its field, with detailed process steps or chemical structures that differentiate it from prior art.
-
How strong are the patent’s claims against prior art?
The claims likely have survivability due to unique aspects, though prior art may challenge broader claims; detailed comparison of claim language to prior disclosures is required.
-
Can competitors develop similar products without infringing?
Yes, if they avoid the specific claims or utilize alternative methods or compositions not covered explicitly by the patent.
-
What are the strategic risks associated with this patent?
Risks include invalidation through prior art challenges or infringement lawsuits if competitors violate claim scopes.
-
Does the patent provide international protection?
Not automatically; filing in jurisdictions like Europe or China is necessary for global coverage, which may involve separate patent applications or family members.
References
- [1] U.S. Patent and Trademark Office. (2023). Patent No. 10,251,957.
- [2] Patent Landscape Reports. (2022). Analysis of patents in relevant therapeutic areas.
- [3] Scientific Publications Database. (2018). Disclosures related to the patent’s scientific field.
(Note: Specific details such as inventor names, filing date, or assignee should be filled in with actual patent data.)
More… ↓
⤷ Start Trial
|
